ALOGLIPTIN vs ALPELISIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ALOGLIPTIN vs ALPELISIB: Safety Overview
| Metric | ALOGLIPTIN | ALPELISIB |
|---|---|---|
| Total FAERS Reports | 1,385 | 8,419 |
| Deaths Reported | 122 | 1,271 |
| Death Rate | 8.8% | 15.1% |
| Hospitalizations | 567 | 1,705 |
| Average Patient Age | 69.0 yrs | 58.8 yrs |
| % Female Patients | 41.0% | 94.7% |
| FDA Approval Date | Jan 25, 2013 | Apr 24, 2024 |
| Manufacturer | Padagis Israel Pharmaceuticals Ltd | Novartis Pharmaceuticals Corporation |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |